←Back to structures
CAKLQF020000021.1__CAH1090616.1__SAMEA5780031_03210__00032
Bact-VirCAKLQF020000021.1__CAH1090616.1__SAMEA5780031_03210__00032
Identity
- Kingdom:
- phage
Quality
97.0
mean pLDDT
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 3-108
Domain cluster:
rep: IMGVR_UViG_3300020357_000170-3300020357-Ga0211611_10025912__D26-104
Pfam (2)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF07366.19 best | SnoaL | 48.8 | 8.60e-13 | 93.4% | 89.7% |
| PF12680.14 | SnoaL_2 | 57.6 | 2.30e-15 | 86.8% | 98.0% |
CATH (69)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3g0kA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.90 | 85.0 | 7.92e-01 | 100.0% | 86.7% |
| 3f9sB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.88 | 84.0 | 7.49e-01 | 100.0% | 92.2% |
| 1tuhA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.88 | 83.0 | 7.67e-01 | 100.0% | 93.9% |
| 3ff2A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.87 | 80.0 | 7.76e-01 | 97.2% | 99.1% |
| 1sjwA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.87 | 81.0 | 7.27e-01 | 99.1% | 88.7% |
| 4lgqA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.87 | 81.0 | 7.42e-01 | 99.1% | 94.7% |
| 3g8zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.87 | 80.0 | 7.47e-01 | 98.1% | 92.2% |
| 3k0zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.87 | 82.0 | 7.17e-01 | 100.0% | 77.9% |
| 3f40A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.87 | 81.0 | 8.03e-01 | 99.1% | 94.6% |
| 3kkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.86 | 81.0 | 7.20e-01 | 100.0% | 88.9% |
| 4lmiB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 81.0 | 7.31e-01 | 100.0% | 79.4% |
| 2k54A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 80.0 | 7.58e-01 | 100.0% | 93.5% |
| 4u13A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 77.0 | 7.67e-01 | 96.2% | 97.2% |
| 3h3hB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 80.0 | 7.63e-01 | 100.0% | 97.5% |
| 2gexA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 80.0 | 7.06e-01 | 100.0% | 84.2% |
| 3f7xA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 79.0 | 7.23e-01 | 99.1% | 94.7% |
| 1nu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 79.0 | 7.01e-01 | 100.0% | 81.4% |
| 3ebtA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 79.0 | 7.27e-01 | 100.0% | 94.7% |
| 3en8A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 79.0 | 7.77e-01 | 100.0% | 97.3% |
| 6p3lA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 79.0 | 7.69e-01 | 100.0% | 97.4% |
| 3ehcB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 78.0 | 7.27e-01 | 99.1% | 93.8% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 78.0 | 7.18e-01 | 99.1% | 93.9% |
| 3dmcA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 77.0 | 7.11e-01 | 100.0% | 91.8% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 77.0 | 7.17e-01 | 99.1% | 90.0% |
| 3fh1A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 78.0 | 7.40e-01 | 100.0% | 93.4% |
| 5evhA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 78.0 | 7.42e-01 | 100.0% | 90.9% |
| 1ar0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 78.0 | 7.35e-01 | 100.0% | 94.4% |
| 5tgnA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 77.0 | 7.66e-01 | 99.1% | 99.1% |
| 3gzbA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 77.0 | 6.72e-01 | 100.0% | 83.1% |
| 3dukA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 77.0 | 7.28e-01 | 100.0% | 92.0% |
| 6a5gA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 74.0 | 6.78e-01 | 96.2% | 94.1% |
| 3nv0B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 6.99e-01 | 100.0% | 89.7% |
| 3ecfA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 7.11e-01 | 100.0% | 85.9% |
| 3blzA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 7.20e-01 | 100.0% | 93.5% |
| 2imjD01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 75.0 | 6.75e-01 | 100.0% | 81.7% |
| 3fkaB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 75.0 | 7.17e-01 | 99.1% | 94.2% |
| 4j8tA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 74.0 | 6.92e-01 | 99.1% | 96.1% |
| 1s5aB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 74.0 | 6.68e-01 | 100.0% | 87.4% |
| 3q90B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 75.0 | 6.95e-01 | 100.0% | 90.8% |
| 2qiyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 75.0 | 6.86e-01 | 100.0% | 97.8% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 71.0 | 6.27e-01 | 97.2% | 100.0% |
| 3lygA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 73.0 | 7.03e-01 | 100.0% | 95.8% |
| 4r80A00 | 3.10.450.630 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 52.0 | 6.09e-01 | 100.0% | 94.7% |
| 3f14A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 72.0 | 7.10e-01 | 99.1% | 98.2% |
| 2g30A02 | 3.30.310.10 | Alpha Beta › 2-Layer Sandwich › TATA-Binding Protein › TATA-Binding Protein | 0.73 | 42.0 | 4.06e-01 | 94.3% | 50.9% |
| 2gxfA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 65.0 | 6.30e-01 | 99.1% | 98.3% |
| 3kztA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 64.0 | 5.88e-01 | 96.2% | 89.4% |
| 3n8bA00 | 3.10.450.700 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 35.0 | 4.05e-01 | 84.9% | 70.7% |
| 1pzdA02 | 3.30.310.10 | Alpha Beta › 2-Layer Sandwich › TATA-Binding Protein › TATA-Binding Protein | 0.66 | 41.0 | 4.03e-01 | 98.1% | 57.4% |
| 3k7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 54.0 | 5.44e-01 | 94.3% | 100.0% |
| 2vckA00 | 3.40.1500.20 | Alpha Beta › 3-Layer(aba) Sandwich › oxygen-dependent coproporphyrinogen oxidase › | 0.63 | 41.0 | 3.28e-01 | 74.5% | 33.2% |
| 4hz9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 55.0 | 5.30e-01 | 98.1% | 97.6% |
| 1wnhA01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 49.0 | 5.08e-01 | 100.0% | 93.0% |
| 3al9A01 | 2.130.10.10 | Mainly Beta › 7 Propeller › Methylamine Dehydrogenase; Chain H › YVTN repeat-like/Quinoprotein amine dehydrogenase | 0.59 | 53.0 | 3.48e-01 | 100.0% | 46.3% |
| 7vd7A01 | 3.10.450.530 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Ribonuclease toxin, BrnT, of type II toxin-antitoxin system | 0.57 | 40.0 | 4.32e-01 | 74.5% | 88.0% |
| 3h4zB03 | 3.15.10.50 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › | 0.56 | 51.0 | 4.20e-01 | 100.0% | 71.2% |
| 3doaA01 | 2.30.310.10 | Mainly Beta › Roll › ibrinogen binding protein from staphylococcus aureus fold › ibrinogen binding protein from staphylococcus aureus domain | 0.56 | 50.0 | 4.42e-01 | 99.1% | 77.8% |
| 3djwA00 | 3.30.160.300 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › | 0.55 | 39.0 | 4.06e-01 | 72.6% | 97.9% |
| 3nqzA02 | 3.10.450.40 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.55 | 40.0 | 4.37e-01 | 100.0% | 97.6% |
| 2h36X00 | 3.30.160.300 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › | 0.55 | 38.0 | 3.86e-01 | 72.6% | 84.3% |
| 4mmhA02 | 2.70.98.70 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.54 | 48.0 | 3.59e-01 | 99.1% | 50.9% |
| 2l33A00 | 3.30.160.20 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › | 0.54 | 38.0 | 4.08e-01 | 73.6% | 92.3% |
| 2jjdF02 | 3.90.190.10 | Alpha Beta › Alpha-Beta Complex › Protein-Tyrosine Phosphatase; Chain A › Protein tyrosine phosphatase superfamily | 0.54 | 40.0 | 2.99e-01 | 76.4% | 59.2% |
| 2v43A01 | 2.50.20.10 | Mainly Beta › Clam › outer membrane lipoprotein receptor (LolB), chain A › Lipoprotein localisation LolA/LolB/LppX | 0.54 | 44.0 | 3.78e-01 | 91.5% | 82.0% |
| 5jmfA02 | 2.70.98.70 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.52 | 46.0 | 3.46e-01 | 99.1% | 52.4% |
| 4bboA00 | 2.40.128.30 | Mainly Beta › Beta Barrel › Lipocalin › Avidin-like | 0.52 | 42.0 | 4.16e-01 | 99.1% | 82.3% |
| 6mlyB01 | 2.115.10.20 | Mainly Beta › 5 Propeller › Tachylectin-2; Chain A › Glycosyl hydrolase domain; family 43 | 0.52 | 46.0 | 3.48e-01 | 100.0% | 40.1% |
| 7jvhC01 | 2.115.10.20 | Mainly Beta › 5 Propeller › Tachylectin-2; Chain A › Glycosyl hydrolase domain; family 43 | 0.51 | 44.0 | 3.16e-01 | 100.0% | 30.6% |
| 5jenA01 | 3.30.565.40 | Alpha Beta › 2-Layer Sandwich › Heat Shock Protein 90 › Fervidobacterium nodosum Rt17-B1 like | 0.50 | 41.0 | 4.13e-01 | 93.4% | 100.0% |
ECOD (80)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 5038381 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.93 | 89.0 | 8.31e-01 | 100.0% | 89.6% |
| 3989349 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.92 | 87.0 | 8.16e-01 | 100.0% | 84.7% |
| 3957839 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.87 | 83.0 | 7.63e-01 | 100.0% | 90.0% |
| 169779 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.87 | 80.0 | 7.76e-01 | 97.2% | 99.1% |
| 3744079 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.87 | 80.0 | 7.49e-01 | 96.2% | 88.8% |
| 5033887 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.87 | 80.0 | 7.74e-01 | 96.2% | 93.9% |
| 169506 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.87 | 81.0 | 8.00e-01 | 99.1% | 93.8% |
| 2163935 | 243.1.1.10 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL | 0.86 | 80.0 | 7.32e-01 | 100.0% | 91.9% |
| 4975052 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.85 | 81.0 | 7.47e-01 | 100.0% | 92.3% |
| 4030906 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.85 | 80.0 | 7.51e-01 | 100.0% | 90.4% |
| 3281821 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.85 | 77.0 | 7.14e-01 | 96.2% | 96.2% |
| 3958160 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.85 | 79.0 | 7.56e-01 | 99.1% | 89.2% |
| 3953609 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.85 | 79.0 | 7.67e-01 | 99.1% | 93.0% |
| 2785694 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.84 | 78.0 | 7.32e-01 | 100.0% | 89.8% |
| 5071336 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.84 | 77.0 | 7.23e-01 | 99.1% | 85.9% |
| 169841 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.83 | 78.0 | 7.39e-01 | 100.0% | 93.4% |
| 1716100 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.83 | 78.0 | 7.42e-01 | 100.0% | 90.9% |
| 4996998 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.83 | 77.0 | 7.52e-01 | 99.1% | 97.4% |
| 1907494 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.83 | 77.0 | 7.66e-01 | 99.1% | 99.1% |
| 169842 | 243.1.1.22 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Lumazine_bd_2 | 0.83 | 77.0 | 7.28e-01 | 100.0% | 92.0% |
| 3938215 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.82 | 77.0 | 6.92e-01 | 100.0% | 83.5% |
| 6397 | 243.1.1.30 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4904 | 0.82 | 76.0 | 7.11e-01 | 100.0% | 85.9% |
| 6388 | 243.1.1.22 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Lumazine_bd_2 | 0.82 | 76.0 | 7.19e-01 | 100.0% | 93.5% |
| 3240257 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.81 | 72.0 | 7.25e-01 | 93.4% | 100.0% |
| 3277756 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.81 | 74.0 | 6.83e-01 | 99.1% | 90.3% |
| 3213694 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.80 | 74.0 | 7.17e-01 | 99.1% | 96.5% |
| 2617498 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.80 | 71.0 | 7.08e-01 | 96.2% | 100.0% |
| 138908 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.79 | 73.0 | 7.03e-01 | 100.0% | 95.8% |
| 3219433 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.79 | 73.0 | 6.85e-01 | 99.1% | 88.0% |
| 2832673 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.79 | 72.0 | 7.01e-01 | 98.1% | 95.6% |
| 3240258 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.78 | 72.0 | 6.91e-01 | 99.1% | 91.7% |
| 169507 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.78 | 72.0 | 7.09e-01 | 99.1% | 98.2% |
| 3238860 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.78 | 72.0 | 7.18e-01 | 100.0% | 100.0% |
| 3270919 | 331.9.1.2 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain › B2-adapt-app_C | 0.78 | 44.0 | 4.29e-01 | 94.3% | 51.3% |
| 3343550 | 243.1.1.53 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › WI12 | 0.78 | 73.0 | 6.48e-01 | 100.0% | 92.4% |
| 3227200 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.78 | 71.0 | 5.93e-01 | 99.1% | 62.3% |
| 3213695 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.77 | 71.0 | 6.57e-01 | 99.1% | 85.4% |
| 3931614 | 331.9.1.2 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain › B2-adapt-app_C | 0.77 | 43.0 | 4.25e-01 | 94.3% | 51.3% |
| 3219432 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.77 | 70.0 | 6.76e-01 | 100.0% | 93.3% |
| 3219435 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.77 | 71.0 | 5.71e-01 | 100.0% | 60.8% |
| 3219430 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.76 | 69.0 | 6.78e-01 | 99.1% | 97.4% |
| 3221045 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.75 | 68.0 | 6.28e-01 | 99.1% | 89.6% |
| 3712575 | 331.9.1.2 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain › B2-adapt-app_C | 0.74 | 43.0 | 4.06e-01 | 95.3% | 49.2% |
| 3217076 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.74 | 66.0 | 6.46e-01 | 97.2% | 99.1% |
| 3214362 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.74 | 59.0 | 6.09e-01 | 85.8% | 100.0% |
| 3593024 | 331.9.1.0 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain | 0.74 | 44.0 | 4.32e-01 | 95.3% | 55.7% |
| 2605238 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.73 | 66.0 | 6.59e-01 | 97.2% | 98.1% |
| 2878158 | 243.1.1.8 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MlaC | 0.72 | 65.0 | 5.52e-01 | 98.1% | 80.8% |
| 4386721 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 60.0 | 5.88e-01 | 99.1% | 86.1% |
| 4949878 | 243.1.1.23 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF3887 | 0.69 | 61.0 | 6.11e-01 | 98.1% | 96.4% |
| 3284679 | 243.1.1.80 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26580 | 0.69 | 62.0 | 6.06e-01 | 99.1% | 95.7% |
| 3973036 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 61.0 | 4.98e-01 | 95.3% | 76.8% |
| 3711273 | 331.9.1.0 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain | 0.67 | 40.0 | 3.90e-01 | 94.3% | 53.5% |
| 3703242 | 331.9.1.0 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain | 0.67 | 40.0 | 3.82e-01 | 94.3% | 50.8% |
| 146266 | 295.1.1.8 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain › DUF3276 | 0.67 | 35.0 | 3.86e-01 | 84.9% | 63.1% |
| 3285547 | 243.1.1.80 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26580 | 0.66 | 58.0 | 5.83e-01 | 96.2% | 96.2% |
| 3630385 | 9.1.1.49 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › DUF7043 | 0.66 | 52.0 | 5.13e-01 | 97.2% | 78.3% |
| 3668772 | 881.1.1.1 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › PsbP | 0.65 | 48.0 | 4.05e-01 | 100.0% | 47.6% |
| 4177861 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.65 | 58.0 | 5.56e-01 | 99.1% | 90.8% |
| 3284847 | 243.1.1.80 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26580 | 0.63 | 56.0 | 5.57e-01 | 98.1% | 95.4% |
| 3658474 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.63 | 46.0 | 4.83e-01 | 94.3% | 85.3% |
| 5045102 | 331.1.1.0 ↗ | a+b two layers › TBP-like › TATA-box binding protein-like › TATA-box binding protein-like | 0.62 | 37.0 | 3.90e-01 | 95.3% | 65.3% |
| 4927674 | 814.1.1.0 ↗ | a+b two layers › Chorismate lyase › Chorismate lyase › Chorismate lyase | 0.61 | 49.0 | 4.47e-01 | 87.7% | 90.3% |
| 3818341 | 331.9.1.4 ↗ | a+b two layers › TBP-like › Subdomain of clathrin and coatomer appendage domain › Subdomain of clathrin and coatomer appendage domain › Coatomer_g_Cpla | 0.59 | 35.0 | 3.98e-01 | 90.6% | 79.5% |
| 4867468 | 5084.3.1.1 ↗ | beta barrels › Outer membrane meander beta-barrels › Autotransporter › Autotransporter › Autotransporter | 0.59 | 34.0 | 4.17e-01 | 86.8% | 89.7% |
| 3915503 | 5.1.4.1 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › WD40 | 0.59 | 42.0 | 2.97e-01 | 100.0% | 24.2% |
| 3883680 | 5.1.4.12 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › Sema | 0.58 | 52.0 | 3.35e-01 | 100.0% | 37.1% |
| 4967348 | 814.1.1.0 ↗ | a+b two layers › Chorismate lyase › Chorismate lyase › Chorismate lyase | 0.57 | 44.0 | 4.34e-01 | 83.0% | 100.0% |
| 4960887 | 814.1.1.0 ↗ | a+b two layers › Chorismate lyase › Chorismate lyase › Chorismate lyase | 0.57 | 43.0 | 4.26e-01 | 82.1% | 100.0% |
| 3211848 | 5.1.4.453 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › Kelch_KLHDC2_KLHL20_DRC7 | 0.56 | 50.0 | 3.43e-01 | 100.0% | 44.2% |
| 4986587 | 814.1.1.0 ↗ | a+b two layers › Chorismate lyase › Chorismate lyase › Chorismate lyase | 0.56 | 42.0 | 4.17e-01 | 82.1% | 100.0% |
| 3163979 | 71.1.1.4 ↗ | beta meanders › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › MucB_RseB | 0.55 | 45.0 | 3.76e-01 | 91.5% | 78.9% |
| 3937047 | 9.1.1.55 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › DUF7045 | 0.54 | 47.0 | 4.53e-01 | 95.3% | 83.3% |
| 3339570 | 331.3.1.3 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › START | 0.54 | 41.0 | 3.09e-01 | 94.3% | 34.0% |
| 3345243 | 331.3.1.3 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › START | 0.54 | 39.0 | 3.05e-01 | 94.3% | 34.2% |
| 5006751 | 71.1.1.8 ↗ | beta meanders › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › LolA_like | 0.54 | 46.0 | 3.89e-01 | 98.1% | 81.1% |
| 3783070 | 5.1.4.119 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › Rav1p_C | 0.52 | 42.0 | 2.95e-01 | 100.0% | 25.8% |
| 3178555 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.52 | 46.0 | 2.80e-01 | 99.1% | 21.3% |
| 3993127 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.52 | 46.0 | 3.04e-01 | 100.0% | 29.1% |
| 4660347 | 12.3.1.6 ↗ | beta sandwiches › Glycosyl hydrolase domain-like › supersandwich › supersandwich › Bgal_small_N | 0.50 | 44.0 | 3.25e-01 | 100.0% | 44.9% |
D2
high
residues 132-239
Domain cluster:
rep: S2_012_000_R2_scaffold_0_prodigal-single.1__X__X__01041__D28-149
CATH (72)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3g8zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.88 | 82.0 | 7.70e-01 | 98.1% | 89.8% |
| 4lmiB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.88 | 82.0 | 7.46e-01 | 100.0% | 77.2% |
| 3f40A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.88 | 78.0 | 7.73e-01 | 99.1% | 90.1% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.87 | 81.0 | 7.60e-01 | 99.1% | 90.7% |
| 3kkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.86 | 81.0 | 7.28e-01 | 100.0% | 85.4% |
| 1tuhA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.86 | 80.0 | 7.48e-01 | 100.0% | 89.3% |
| 3gzrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 79.0 | 7.19e-01 | 100.0% | 88.7% |
| 3dmcA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 79.0 | 7.32e-01 | 100.0% | 91.8% |
| 3en8A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 78.0 | 7.76e-01 | 100.0% | 94.6% |
| 3g0kA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 79.0 | 7.39e-01 | 100.0% | 84.4% |
| 4u13A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 77.0 | 7.71e-01 | 99.1% | 97.2% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 77.0 | 7.18e-01 | 99.1% | 90.2% |
| 5aigA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 77.0 | 7.33e-01 | 99.1% | 90.3% |
| 2k54A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 78.0 | 7.43e-01 | 100.0% | 91.1% |
| 4lgqA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 7.05e-01 | 99.1% | 91.0% |
| 4mjdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 7.50e-01 | 100.0% | 94.7% |
| 1nu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 6.83e-01 | 100.0% | 77.9% |
| 3hk4A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 7.37e-01 | 99.1% | 98.3% |
| 3k0zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 6.77e-01 | 100.0% | 77.9% |
| 3gzbA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 6.69e-01 | 100.0% | 79.9% |
| 2bngC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.82 | 76.0 | 6.91e-01 | 100.0% | 78.6% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 75.0 | 7.04e-01 | 99.1% | 86.2% |
| 1buqA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 75.0 | 7.15e-01 | 100.0% | 89.6% |
| 3dxoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 75.0 | 7.28e-01 | 99.1% | 96.6% |
| 3fljA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 74.0 | 6.69e-01 | 100.0% | 75.2% |
| 1ar0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 75.0 | 7.12e-01 | 100.0% | 91.2% |
| 3ehcB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 74.0 | 6.99e-01 | 99.1% | 89.8% |
| 3ecfA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 73.0 | 6.83e-01 | 100.0% | 82.0% |
| 3hx8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 74.0 | 6.94e-01 | 100.0% | 94.5% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 73.0 | 6.81e-01 | 100.0% | 92.4% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 73.0 | 7.03e-01 | 99.1% | 97.5% |
| 3lygA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 73.0 | 7.03e-01 | 100.0% | 91.7% |
| 3gwrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 71.0 | 6.69e-01 | 98.1% | 92.9% |
| 2rgqB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 71.0 | 6.66e-01 | 100.0% | 92.5% |
| 3f8xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 72.0 | 6.70e-01 | 100.0% | 82.6% |
| 2owpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 72.0 | 6.74e-01 | 100.0% | 89.1% |
| 2chcC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 70.0 | 6.13e-01 | 100.0% | 76.7% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 69.0 | 6.02e-01 | 100.0% | 76.8% |
| 1tp6A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 69.0 | 6.56e-01 | 99.1% | 97.6% |
| 4orlA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 67.0 | 6.70e-01 | 99.1% | 95.5% |
| 4r80A00 | 3.10.450.630 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 48.0 | 5.65e-01 | 100.0% | 92.1% |
| 3h51A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 68.0 | 6.23e-01 | 100.0% | 85.2% |
| 1tu1A00 | 3.40.1000.10 | Alpha Beta › 3-Layer(aba) Sandwich › Protein Transport Mog1p; Chain A › Mog1/PsbP, alpha/beta/alpha sandwich | 0.75 | 46.0 | 4.15e-01 | 98.1% | 46.5% |
| 3ke7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 66.0 | 6.20e-01 | 99.1% | 86.5% |
| 3fkaB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 68.0 | 6.53e-01 | 100.0% | 93.3% |
| 3tfzB00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.68 | 41.0 | 3.53e-01 | 95.4% | 38.8% |
| 2d4rA00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.68 | 41.0 | 3.69e-01 | 96.3% | 43.8% |
| 4n6tA00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 47.0 | 5.42e-01 | 99.1% | 97.5% |
| 2lyxA00 | 3.10.450.390 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Protein of unknown function DUF3889 | 0.67 | 44.0 | 4.86e-01 | 96.3% | 83.9% |
| 3k7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 59.0 | 5.96e-01 | 96.3% | 100.0% |
| 4exrA02 | 3.10.450.40 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 38.0 | 4.44e-01 | 100.0% | 88.7% |
| 2ra6C00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.63 | 41.0 | 3.73e-01 | 95.4% | 49.0% |
| 2xglA00 | 3.10.450.300 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › YebF/Colicin-M immunity protein | 0.63 | 47.0 | 5.11e-01 | 100.0% | 93.4% |
| 4wfvA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.62 | 43.0 | 3.83e-01 | 98.1% | 49.7% |
| 1dzkA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.62 | 41.0 | 3.75e-01 | 99.1% | 50.0% |
| 2l4vA00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 48.0 | 4.43e-01 | 99.1% | 68.1% |
| 3ci0K01 | 3.30.1300.30 | Alpha Beta › 2-Layer Sandwich › Pantoate--beta-alanine Ligase; Chain: A,domain 2 › GSPII I/J protein-like | 0.59 | 36.0 | 3.72e-01 | 99.1% | 62.5% |
| 1pbyA02 | 2.40.128.120 | Mainly Beta › Beta Barrel › Lipocalin › Quinohemoprotein amine dehydrogenase alpha subunit, domain 2 | 0.59 | 45.0 | 4.61e-01 | 100.0% | 83.0% |
| 1y8cA02 | 2.20.25.110 | Mainly Beta › Single Sheet › N-terminal domain of TfIIb › S-adenosyl-L-methionine-dependent methyltransferases | 0.56 | 30.0 | 3.88e-01 | 88.9% | 93.3% |
| 1y0gA00 | 2.40.128.110 | Mainly Beta › Beta Barrel › Lipocalin › Lipid/polyisoprenoid-binding, YceI-like | 0.56 | 48.0 | 4.18e-01 | 95.4% | 81.7% |
| 1lkeA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.56 | 47.0 | 4.20e-01 | 100.0% | 64.3% |
| 3htyA00 | 2.40.128.280 | Mainly Beta › Beta Barrel › Lipocalin › | 0.56 | 41.0 | 4.39e-01 | 98.1% | 89.4% |
| 4k15A00 | 2.60.40.3860 | Mainly Beta › Sandwich › Immunoglobulin-like › | 0.55 | 33.0 | 3.09e-01 | 100.0% | 45.7% |
| 3d2lA02 | 2.20.25.110 | Mainly Beta › Single Sheet › N-terminal domain of TfIIb › S-adenosyl-L-methionine-dependent methyltransferases | 0.55 | 33.0 | 3.93e-01 | 90.7% | 98.4% |
| 6f91A01 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.55 | 44.0 | 3.30e-01 | 87.0% | 77.0% |
| 3tqmA00 | 3.30.160.100 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Ribosome hibernation promotion factor-like | 0.55 | 37.0 | 3.99e-01 | 100.0% | 84.4% |
| 2ns9A01 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.54 | 44.0 | 4.01e-01 | 100.0% | 64.9% |
| 6f90A01 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.54 | 43.0 | 3.27e-01 | 87.0% | 73.4% |
| 6jhpA01 | 2.70.98.60 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › alpha-galactosidase from lactobacil brevis | 0.53 | 46.0 | 3.43e-01 | 99.1% | 51.2% |
| 7wffb01 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.52 | 46.0 | 3.42e-01 | 100.0% | 40.7% |
| 1zc0A00 | 3.90.190.10 | Alpha Beta › Alpha-Beta Complex › Protein-Tyrosine Phosphatase; Chain A › Protein tyrosine phosphatase superfamily | 0.51 | 38.0 | 2.84e-01 | 77.8% | 56.3% |
| 4ikcA00 | 3.90.190.10 | Alpha Beta › Alpha-Beta Complex › Protein-Tyrosine Phosphatase; Chain A › Protein tyrosine phosphatase superfamily | 0.51 | 39.0 | 2.91e-01 | 80.6% | 56.2% |
ECOD (84)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3989349 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.93 | 84.0 | 7.94e-01 | 100.0% | 82.3% |
| 1086744 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.88 | 82.0 | 7.46e-01 | 100.0% | 77.2% |
| 169506 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.88 | 78.0 | 7.70e-01 | 99.1% | 89.3% |
| 3962383 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.87 | 82.0 | 7.78e-01 | 100.0% | 87.2% |
| 3989344 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.86 | 81.0 | 7.69e-01 | 100.0% | 88.0% |
| 6384 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.86 | 80.0 | 7.48e-01 | 100.0% | 89.3% |
| 3970325 | 243.1.1.10 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL | 0.85 | 78.0 | 7.10e-01 | 97.2% | 85.0% |
| 1948932 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.85 | 75.0 | 7.62e-01 | 99.1% | 96.2% |
| 6395 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.85 | 78.0 | 7.37e-01 | 100.0% | 83.5% |
| 3955856 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.84 | 77.0 | 7.16e-01 | 97.2% | 83.1% |
| 170206 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.84 | 79.0 | 7.36e-01 | 100.0% | 83.7% |
| 5071336 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.84 | 78.0 | 7.32e-01 | 99.1% | 83.6% |
| 1349151 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.84 | 77.0 | 7.71e-01 | 99.1% | 97.2% |
| 4926997 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.83 | 75.0 | 7.62e-01 | 99.1% | 98.1% |
| 3271321 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.83 | 76.0 | 7.03e-01 | 98.1% | 82.2% |
| 3273514 | 243.1.1.36 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_5 | 0.83 | 76.0 | 7.13e-01 | 98.1% | 85.4% |
| 6411 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.83 | 78.0 | 7.43e-01 | 100.0% | 91.1% |
| 1949089 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.83 | 74.0 | 7.06e-01 | 100.0% | 83.2% |
| 3253090 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.83 | 76.0 | 7.60e-01 | 98.1% | 99.1% |
| 1949057 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.83 | 74.0 | 7.14e-01 | 100.0% | 85.2% |
| 1087544 | 243.1.1.10 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL | 0.82 | 76.0 | 7.03e-01 | 99.1% | 90.3% |
| 3725667 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.82 | 77.0 | 7.29e-01 | 100.0% | 96.8% |
| 3288868 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.82 | 76.0 | 7.30e-01 | 99.1% | 91.7% |
| 6374 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.82 | 76.0 | 7.23e-01 | 100.0% | 89.6% |
| None | — | 0.81 | 76.0 | 7.19e-01 | 100.0% | 89.6% | |
| 169965 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.81 | 73.0 | 6.74e-01 | 99.1% | 76.5% |
| 3203679 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.80 | 74.0 | 6.36e-01 | 98.1% | 75.6% |
| 4806775 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.80 | 74.0 | 7.21e-01 | 99.1% | 97.4% |
| 4927742 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 66.0 | 6.93e-01 | 99.1% | 97.0% |
| 170212 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.79 | 73.0 | 7.03e-01 | 99.1% | 97.5% |
| 4863136 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.79 | 74.0 | 7.02e-01 | 100.0% | 87.9% |
| 3596331 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.79 | 73.0 | 6.84e-01 | 100.0% | 89.8% |
| 3241172 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.78 | 74.0 | 7.21e-01 | 100.0% | 95.7% |
| 2033779 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.78 | 71.0 | 6.76e-01 | 100.0% | 95.3% |
| 2617498 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.77 | 70.0 | 7.03e-01 | 98.1% | 100.0% |
| 4119121 | 243.1.1.34 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › YchJ_M-like | 0.76 | 63.0 | 6.61e-01 | 99.1% | 96.0% |
| 3970330 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.76 | 65.0 | 6.05e-01 | 92.6% | 77.0% |
| 1146735 | 243.1.1.29 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4783 | 0.75 | 67.0 | 6.70e-01 | 99.1% | 95.5% |
| 2644388 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 70.0 | 6.52e-01 | 100.0% | 87.7% |
| 3938215 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.74 | 68.0 | 6.24e-01 | 100.0% | 83.5% |
| 3587998 | 243.1.1.102 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF28180 | 0.74 | 67.0 | 6.80e-01 | 100.0% | 99.0% |
| 4949068 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.74 | 67.0 | 6.73e-01 | 99.1% | 97.3% |
| 3286756 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.73 | 67.0 | 6.62e-01 | 99.1% | 93.9% |
| 5052916 | 243.1.1.22 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Lumazine_bd_2 | 0.73 | 68.0 | 6.35e-01 | 100.0% | 87.7% |
| 358014 | 243.1.1.22 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Lumazine_bd_2 | 0.73 | 68.0 | 6.53e-01 | 100.0% | 93.3% |
| 4983588 | 295.1.1.0 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain | 0.73 | 39.0 | 4.59e-01 | 92.6% | 74.7% |
| 4104010 | 243.1.1.23 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF3887 | 0.72 | 59.0 | 6.25e-01 | 95.4% | 100.0% |
| 2605238 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.70 | 63.0 | 6.37e-01 | 100.0% | 100.0% |
| 4930408 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 60.0 | 6.24e-01 | 94.4% | 99.0% |
| 3287996 | 243.1.1.80 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26580 | 0.69 | 59.0 | 6.02e-01 | 96.3% | 95.2% |
| 4977517 | 295.1.1.0 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain | 0.69 | 37.0 | 4.34e-01 | 93.5% | 74.7% |
| 3241827 | 243.1.1.75 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26530 | 0.69 | 63.0 | 6.00e-01 | 100.0% | 87.9% |
| 4929282 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.68 | 44.0 | 5.20e-01 | 95.4% | 94.7% |
| 2617497 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.68 | 61.0 | 6.06e-01 | 100.0% | 100.0% |
| 144571 | 331.3.1.11 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Polyketide_cyc2 | 0.68 | 41.0 | 3.50e-01 | 97.2% | 38.1% |
| 3952896 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 60.0 | 5.77e-01 | 96.3% | 85.5% |
| 5083728 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 58.0 | 6.02e-01 | 98.1% | 100.0% |
| 3278140 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 60.0 | 6.00e-01 | 97.2% | 98.2% |
| 3386770 | 243.1.1.8 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MlaC | 0.67 | 58.0 | 5.06e-01 | 95.4% | 82.4% |
| 152844 | 243.3.1.8 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3889 | 0.67 | 44.0 | 4.86e-01 | 96.3% | 83.9% |
| 3895620 | 331.3.1.5 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Polyketide_cyc | 0.67 | 39.0 | 3.40e-01 | 97.2% | 37.6% |
| 3282696 | 243.1.1.80 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26580 | 0.66 | 57.0 | 5.89e-01 | 96.3% | 100.0% |
| 4929919 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.65 | 53.0 | 5.64e-01 | 98.1% | 100.0% |
| 3619070 | 331.3.1.5 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › Polyketide_cyc | 0.65 | 39.0 | 3.41e-01 | 97.2% | 38.8% |
| 3763572 | 9.1.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › Lipocalin | 0.65 | 43.0 | 3.83e-01 | 98.1% | 47.1% |
| 3288112 | 243.1.1.69 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF6459 | 0.64 | 57.0 | 5.68e-01 | 100.0% | 97.2% |
| 3939672 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.63 | 47.0 | 4.69e-01 | 100.0% | 76.4% |
| 3991735 | 9.1.1.49 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › DUF7043 | 0.62 | 48.0 | 4.73e-01 | 96.3% | 76.5% |
| 3221974 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.62 | 53.0 | 5.43e-01 | 99.1% | 98.1% |
| 3511507 | 9.1.1.49 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › DUF7043 | 0.61 | 49.0 | 4.74e-01 | 96.3% | 77.1% |
| 3216577 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.61 | 55.0 | 5.46e-01 | 100.0% | 100.0% |
| 3976580 | 243.1.1.21 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF3828 | 0.60 | 54.0 | 4.83e-01 | 100.0% | 81.0% |
| 3225189 | 5.1.4.369 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › EMC1_C, Beta-prop_EMC1_N | 0.60 | 42.0 | 2.49e-01 | 100.0% | 9.2% |
| 4029119 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.59 | 47.0 | 3.23e-01 | 100.0% | 26.0% |
| 4993981 | 243.5.1.0 ↗ | a+b two layers › Cystatin-like › Amine oxidase N-terminal region › Amine oxidase N-terminal region | 0.57 | 39.0 | 4.34e-01 | 100.0% | 95.0% |
| 4083689 | 283.2.1.1 ↗ | a+b duplicates or obligate multimers › Creatinase/aminopeptidase-like › gpW/gp25-like › gpW/gp25-like › GPW_gp25 | 0.56 | 38.0 | 3.80e-01 | 100.0% | 67.9% |
| 3937921 | 5.1.3.170 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 6-bladed › Beta-prop_IFT140_2nd | 0.56 | 43.0 | 3.10e-01 | 100.0% | 27.3% |
| 3573723 | 5.1.4.37 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › Nup160 | 0.54 | 45.0 | 2.96e-01 | 100.0% | 19.6% |
| 3955095 | 881.1.1.8 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › PknH_C | 0.54 | 44.0 | 3.64e-01 | 89.8% | 64.3% |
| 3840132 | 9.5.1.1 ↗ | beta barrels › Lipocalins/Streptavidin › Hypothetical protein TT1927B › Hypothetical protein TT1927B › YceI | 0.53 | 45.0 | 3.89e-01 | 90.7% | 75.6% |
| 3698170 | 5.1.3.8 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 6-bladed › Arylesterase | 0.53 | 48.0 | 3.26e-01 | 100.0% | 28.0% |
| 4976921 | 206.1.1.0 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase | 0.52 | 40.0 | 2.92e-01 | 84.3% | 52.8% |
| 5015089 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.52 | 43.0 | 3.34e-01 | 100.0% | 40.4% |
| 3496018 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.50 | 45.0 | 2.95e-01 | 100.0% | 26.0% |